Every injector knows the moment. A patient points to the area under their chin, asks what can be done, and then hears the words "series of injections" and "swelling for a few days." Some book anyway. Many say they will think about it and never come back. That patient still wants a more defined jawline. They just want a different path to get there.

At Conformational Aesthetics, a doctor-founded skincare company built around a South Korean clinical breakthrough, we built Conforma Reduce for exactly that patient. It brings deoxycholic acid into a daily at-home routine, so your practice can say yes to the patient who says no to needles. This guide will walk you through why patients turn down Kybella, who topical DCA is right for, and how to position it alongside the treatments you already offer.

Table of Contents

• Why Patients Say No to Kybella
• What Topical DCA Offers That Injections Don't
• Who Is the Right Patient for Topical DCA?
• How Topical DCA Fits Your Treatment Menu
• How to Introduce Topical DCA in Your Consultations
• What Wholesale Partners Get
• Frequently Asked Questions
• The Bottom Line on Offering Topical DCA Alongside Kybella

Why Patients Say No to Kybella

Kybella is an FDA-approved injectable made with deoxycholic acid (DCA), a molecule the body makes naturally to help break down dietary fat. It works, and it has earned its place on most med spa menus. But the treatment asks a lot of patients:

• Needles. Each session involves multiple injections under the chin. For needle-averse patients, that alone ends the conversation.
• Multiple sessions. Treatment is often spread across several appointments, up to six, about a month apart.
• Swelling and downtime. Swelling, bruising, and numbness for several days are common, which is hard to schedule around work, travel, or events.
• Cost per visit. Paying for a series up front is a bigger commitment than many patients are ready to make on day one.

None of that makes Kybella the wrong choice. It means a portion of your interested patients will always walk away from it. Topical DCA gives you something to offer them before they do.

What Topical DCA Offers That Injections Don't

Conforma Reduce delivers the same active ingredient in a cosmetic cream. Patients apply it to the under-chin and jawline twice a day at home, with no needles, no appointments, and no downtime.

The challenge with any DCA cream has always been absorption. Most formulas cannot get past the skin's outer layer. Conformational Change Technology™, developed in South Korea, changes the physical shape of the active molecules, restructuring them into clusters of 2 to 5 nanometers (a nanometer is one billionth of a meter) so they can travel beyond the skin's surface. The result is up to 10x deeper absorption than traditional formulations.

In a 2023 study published in Skin Research & Technology, a topical DCA formula reduced double chin surface area by 12.5% and under-chin (submental) fat volume by 15%, with no adverse effects reported.

In other words, topical DCA trades speed for ease. Results are gradual rather than dramatic, typically visible in 30 to 60 days, but the barrier to starting is close to zero.

Who Is the Right Patient for Topical DCA?

Topical DCA works best when it matches the patient's goals and expectations. Strong candidates include:

• Needle-averse patients who want a more defined jawline but will not consider injections.
• Patients with mild to moderate fullness under the chin who want gradual refinement rather than a dramatic change.
• Kybella patients between or after a series who want a daily step to maintain their contour.
• RF microneedling patients who want to target fullness while the in-office treatment tightens skin. Our guide to pairing topical DCA with RF microneedling covers that protocol.
• GLP-1 and weight loss patients who still notice softness under the chin, an area shaped by genetics and skin laxity (loose skin), not body weight alone.
• Patients with an event coming up who cannot risk visible swelling.

Conforma Reduce is formulated for the under-chin and jawline only, not the cheeks. Patients with significant skin laxity are better served by skin tightening or a surgical consult, with Conforma Reduce as a supporting step.

How Topical DCA Fits Your Treatment Menu

The simplest way to add topical DCA is as three levels of the same goal. Every patient who asks about their chin leaves with an option that fits them.

The at-home level often becomes the first step toward the others. A patient who starts with a cream and sees progress is far more likely to come back for an in-office treatment than one who left with nothing.

How to Introduce Topical DCA in Your Consultations

Most of the work happens in the first conversation. Here is a five-step flow your team can use.

1. Ask About Needles and Timing Early

Before recommending a treatment, ask two questions: how the patient feels about injections, and whether they have an event coming up. The answers tell you which level to lead with.

2. Show Real Before-and-After Photos

Photos do more than any explanation. Partners receive real customer before-and-afters to use in consultations, so patients can see what gradual change looks like.

3. Set Clear Expectations

Explain that results build over time with twice-daily use, typically visible in 30 to 60 days, and that they are more gradual than an injection. Patients who know what to expect stay consistent.

4. Send Them Home With a Plan

Recommend a two-bottle starting plan so patients have enough product to reach visible results, and show them how to apply it before they leave.

5. Follow Up at Week Four

A quick check-in with a progress photo keeps patients motivated, gives your team a reason to reconnect, and opens the door to a reorder or an in-office upgrade.

Before

After, 6 weeks

Real customer. Individual results vary.

"Within the first month I seriously saw a significant difference. I've been told by my friends and coworkers how much my face looks tighter."
Mackenzie, Conforma Reduce user

What Wholesale Partners Get

Conforma Reduce is designed to live inside your practice, not compete with it. Partners receive:

• A differentiated offering. A topical DCA patients cannot find at the drugstore.
• 55% gross retail margin at recommended retail pricing.
• No minimum orders. Start with what fits your practice and grow with demand.
• First-to-market opportunity. Your practice may be the first provider in your area, subject to availability.
• Training and support. Product and protocol training, consultation talking points, before-and-after photos, marketing materials, and samples to try first.

Frequently Asked Questions

Does topical DCA work as well as Kybella?

No, and it is not meant to. Kybella delivers deoxycholic acid by injection and typically produces more change per treatment. Conforma Reduce delivers the same active ingredient in a cream applied twice daily at home, with gradual results and no downtime. It is the right fit for patients who will not do injections or want a maintenance step.

Can patients use Conforma Reduce with Kybella?

Many practices position it as a maintenance step during or after a Kybella series. Your clinical team sets the timing around injection sessions, and patients should not apply it to swollen, bruised, or irritated skin.

Who should not use Conforma Reduce?

Conforma Reduce is formulated for the under-chin and jawline only, not the cheeks. Patients with significant loose skin may need skin tightening or a surgical consult instead.

How long until patients see results?

With consistent twice-daily use, most patients see visible change in 30 to 60 days. Results build gradually, which is why a two-bottle starting plan and a week-four check-in help patients stay on track.

What should we charge patients?

Conforma Reduce retails for $210 on our website. Wholesale partners receive pricing structured for clinic economics, with details shared during your intro call.

Is there a minimum order?

No. Practices can start with a small order that fits their patient base and reorder as demand grows. There is no large opening inventory commitment, so you can introduce the line, see how patients respond, and scale from there.

The Bottom Line on Offering Topical DCA Alongside Kybella

The patient who says no to needles has not said no to your practice. Conforma Reduce gives your team a clinically studied, needle-free option to offer in that moment, a maintenance step for your injection patients, and a reason for every patient to stay on a plan with you. That is the lane we built it for.

Interested in bringing Conformational Aesthetics to your practice? Schedule a brief introduction call to explore wholesale pricing, training, and the opportunity to become the first provider in your area.

BOOK AN INTRO CALL

Learn more about wholesale partnership

Direct From South Korea. Clinical Results. No Appointments Required.

Conforma Reduce is a cosmetic skincare product. Individual results vary.